YF476 and Type I Gastric Carcinoids (Norway)

NCT01444014 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulties with recruitment

Conditions

Chronic Atrophic Gastritis
Hypergastrinemia
Type I Gastric Carcinoids

Interventions

DRUG: YF476

Sponsor

Trio Medicines Ltd.

Collaborators

[object Object]